The MatTek Story — How the Three Rs Principles Led to 3-D Tissue Success!

MatTek Corporation has been working diligently for over 15 years to replace traditional animal-based toxicity and efficacy tests with alternative test methods based on human-cell derived, three-dimensional (3-D) tissue models. First discussed in detail by W.M.S. Russell and R.L. Burch 50 years ago in their book, The Principles of Humane Experimental Technique, and now fully integrated into forward-looking publications such as Toxicity Testing in the 21st Century: A Vision and a Strategy, the concept of replacing animals in test procedures with human cells and/or human cell-derived in vitro 3-D tissues is being embraced by the world's research scientists and toxicologists at an ever-increasing rate. 3-D in vitro models are being utilised not only for humanitarian reasons, but also because human 3-D tissues, in particular, produce more-physiologically relevant scientific data. Early on in MatTek's efforts to develop this alternative test method, senior management sought the assistance of experts within the in vitro testing and animal rights communities, to help define the specific in vitro human 3-D tissue products needed and navigate the regulatory landscape, especially in Europe where the replacement of animal-based testing with non-animal alternative test methods was well underway. MatTek was fortunate to receive that expert assistance on both fronts from Professor Michael Balls, who at that time was the newly-elected first director of ECVAM. In 1997, with the guidance and support of Professor Balls and others in the animal rights community, MatTek began the effort to validate several of its human 3-D tissue-based alternative test methods. Today, two MatTek human cell-derived 3-D tissue-based test methods are validated as full replacements for existing animal-based tests, with more tests in the validation pipeline. In addition, MatTek in vitro tissue models are in use worldwide by chemical, pharmaceutical and consumer product companies, as evidenced by citations in hundreds of patents and scientific articles from these industries. This article concludes with MatTek's thoughts on the direction that human 3-D tissue-based in vitro testing will take in the future.

[1]  Claus-Michael Lehr,et al.  Reconstructed Human Epidermis for Skin Absorption Testing: Results of the German Prevalidation Study , 2006, Alternatives to laboratory animals : ATLA.

[2]  W. Russell,et al.  Ethical and Scientific Considerations Regarding Animal Testing and Research , 2011, PloS one.

[3]  M. Bracher,et al.  Predictive ability of reconstructed human epidermis equivalents for the assessment of skin irritation of cosmetics. , 2002, Toxicology in vitro : an international journal published in association with BIBRA.

[4]  Claus-Michael Lehr,et al.  The Use of Reconstructed Human Epidermis for Skin Absorption Testing: Results of the Validation Study , 2008, Alternatives to laboratory animals : ATLA.

[5]  Valérie Zuang,et al.  The ECVAM International Validation Study on in Vitro Tests for Acute Skin Irritation: Report on the Validity of the EPISKIN and EpiDerm Assays and on the Skin Integrity Function Test a , 2007, Alternatives to laboratory animals : ATLA.

[6]  R Roguet,et al.  A prevalidation study on in vitro tests for acute skin irritation. results and evaluation by the Management Team. , 2001, Toxicology in vitro : an international journal published in association with BIBRA.

[7]  H. Kandárová,et al.  In Vitro Skin Irritation Testing: Improving the Sensitivity of the EpiDerm Skin Irritation Test Protocol , 2009, Alternatives to laboratory animals : ATLA.

[8]  David J Brenner,et al.  Biological effects in unirradiated human tissue induced by radiation damage up to 1 mm away. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[9]  Manfred Liebsch,et al.  Comparison of human skin irritation patch test data with in vitro skin irritation assays and animal data , 2010, Contact dermatitis.

[10]  Elisabeth Schmidt,et al.  The EpiDerm Test Protocol for the Upcoming ECVAM Validation Study on In Vitro Skin Irritation Tests — An Assessment of the Performance of the Optimised Test , 2005, Alternatives to laboratory animals : ATLA.

[11]  H. Spielmann,et al.  [Development of a new in vitro test for dermal phototoxicity using a model of reconstituted human epidermis] , 1997, ALTEX.

[12]  M Liebsch,et al.  Phototoxicity of bergamot oil assessed by in vitro techniques in combination with human patch tests. , 2007, Toxicology in vitro : an international journal published in association with BIBRA.

[13]  M. Liebsch,et al.  ECVAM feasibility study: Can the prevalidated in vitro skin model phototoxicity assay be upgraded to quantify phototoxic potency of topical phototoxins? , 2005 .

[14]  Horst Spielmann,et al.  Optimisation of the EpiDerm test protocol for the upcoming ECVAM validation study on in vitro skin irritation tests. , 2004, ALTEX.

[15]  C. Cohen,et al.  Refinement of the Episkin protocol for the assessment of acute skin irritation of chemicals: follow-up to the ECVAM prevalidation study. , 2002, Toxicology in vitro : an international journal published in association with BIBRA.

[16]  K. Renskers,et al.  Evaluation of the EpiOcular((TM)) Tissue Model as an Alternative to the Draize Eye Irritation Test. , 1998, Toxicology in vitro : an international journal published in association with BIBRA.

[17]  Jose Cotovio,et al.  The In Vitro Acute Skin Irritation of Chemicals: Optimisation of the EPISKIN Prediction Model within the Framework of the ECVAM Validation Process , 2005, Alternatives to laboratory animals : ATLA.

[18]  M Liebsch,et al.  The ECVAM International Validation Study on In Vitro Tests for Skin Corrosivity. 2. Results and Evaluation by the Management Team. , 1998, Toxicology in vitro : an international journal published in association with BIBRA.

[19]  Valérie Zuang,et al.  Follow-up to the ECVAM Prevalidation Study on In Vitro Tests for Acute Skin Irritation , 2002, Alternatives to laboratory animals : ATLA.

[20]  H. Kandárová,et al.  Expanded utilization of the EpiOcular™ human corneal tissue model for ocular irritation tests , 2007 .

[21]  Amy Rispin,et al.  Ensuring quality of in vitro alternative test methods: Current practice. , 2006, Regulatory toxicology and pharmacology : RTP.

[22]  J. Southee,et al.  New epidermal model for dermal irritancy testing. , 1994, Toxicology in vitro : an international journal published in association with BIBRA.

[23]  D. Basketter,et al.  Comparison of human skin irritation and photo-irritation patch test data with cellular in vitro assays and animal in vivo data , 2008 .

[24]  M Liebsch,et al.  The ECVAM Prevalidation Study on the Use of EpiDerm for Skin Corrosivity Testing , 2000, Alternatives to laboratory animals : ATLA.

[25]  M. Blazka,et al.  163 Evaluating the ocular irritation potential of 54 test articles using the epiocular™ human tissue construct model (OCL-200) , 2003 .

[26]  H. Kandárová,et al.  An in vitro skin irritation test (SIT) using the EpiDerm reconstructed human epidermal (RHE) model. , 2009, Journal of visualized experiments : JoVE.

[27]  M. Aardema,et al.  Intralaboratory and interlaboratory evaluation of the EpiDerm 3D human reconstructed skin micronucleus (RSMN) assay. , 2009, Mutation research.

[28]  M Liebsch,et al.  application of the human dermal model skin(2) ZK 1350 to phototoxicity and skin corrosivity testing. , 1995, Toxicology in vitro : an international journal published in association with BIBRA.